Rheumatoid Arthritis Pipeline Therapies
Oct 04, 2024
Which Key Player Holds the Potential to Corner the Rheumatoid Arthritis Therapeutics Market?
Rheumatoid Arthritis is a chronic, inflammatory autoimmune disease that leads to progressive and destructive polyarthritis and affects approximately 1% of the population. The rheumatoid arthritis population is characterized by chronic pain and joint destruction that usually progress from distal to more proximal joi...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
